Consortium for Women's Health Equality Noninvasive Prenatal Testing Addressing the Cervical Cancer Screening Disparities Gap Advances in the Testing for Preterm Premature Rupture of Membrane Better For Women Series Cervical Cancer Screening: Protecting and Improving Health Outcomes of Women Combination Regimen of Estradiol and Progesterone Endometriosis Enhanced Recovery for Cesarean Deliveries in the United States: Perspectives From the Front Lines – Part 1 Enhanced Recovery for Cesarean Deliveries in the United States: Perspectives From the Front Lines – Part 2 Long-Lasting, Reversible Contraception Management of Uterine Fibroids Menopause Mycoplasma Genitalium Infections The only FDA approved combination regimen of estradiol and progesterone Uterine Fibroid

Consortium for Women's Health EqualityNoninvasive Prenatal TestingAddressing the Cervical Cancer Screening Disparities GapAdvances in the Testing for Preterm Premature Rupture of MembraneBetter For Women SeriesCervical Cancer Screening: Protecting and Improving Health Outcomes of WomenCombination Regimen of Estradiol and ProgesteroneEndometriosisEnhanced Recovery for Cesarean Deliveries in the United States: Perspectives From the Front Lines – Part 1Enhanced Recovery for Cesarean Deliveries in the United States: Perspectives From the Front Lines – Part 2Long-Lasting, Reversible ContraceptionManagement of Uterine FibroidsMenopauseMycoplasma Genitalium InfectionsThe only FDA approved combination regimen of estradiol and progesteroneUterine Fibroid

Clinical

View More Contraception COVID-19 Gynecology Legally Speaking Life Transitions Obstetrics Vulvovaginal Well Woman

ContraceptionCOVID-19GynecologyLegally SpeakingLife TransitionsObstetricsVulvovaginalWell Woman

News

All News Residents Corner Practice Management

All NewsResidents CornerPractice Management

Media

K-Cast Medical World News Podcasts Quizzes Videos Viewpoints

K-CastMedical World NewsPodcastsQuizzesVideosViewpoints

Conferences

Conference Coverage Conference Listing

Conference CoverageConference Listing

Publications

Digital Edition Digital Supplements Supplements and Featured Publications

Digital EditionDigital SupplementsSupplements and Featured Publications

CME/CE

Resources

Job Board

eNewsletter Print Subscription

eNewsletterPrint Subscription

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

Spotlight

Consortium for Women's Health Equality
Noninvasive Prenatal Testing
Addressing the Cervical Cancer Screening Disparities Gap
Advances in the Testing for Preterm Premature Rupture of Membrane
Better For Women Series
Cervical Cancer Screening: Protecting and Improving Health Outcomes of Women
Combination Regimen of Estradiol and Progesterone
Endometriosis
Enhanced Recovery for Cesarean Deliveries in the United States: Perspectives From the Front Lines – Part 1
Enhanced Recovery for Cesarean Deliveries in the United States: Perspectives From the Front Lines – Part 2
Long-Lasting, Reversible Contraception
Management of Uterine Fibroids
Menopause
Mycoplasma Genitalium Infections
The only FDA approved combination regimen of estradiol and progesterone
Uterine Fibroid

ClinicalSee All >

Contraception
COVID-19
Gynecology
Legally Speaking
Life Transitions
Obstetrics
Vulvovaginal
Well Woman

Advertise
Contact Us
Job Board
Editorial
Terms of Use
Privacy Policy
Do Not Sell My Personal Information

Atypical antipsychotics may raise LUTS risk in women

December 1, 2012

Women taking atypical antipsychotic medications (AAPs) have about a 3-fiold higher prevalence of lower urinary tract symptoms (LUTS) compared with nonusers, a study on the presence of LUTS among users of psychoactive medications has found.